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Background
Gene promoter hypermethylation is now regarded as a
promising biomarker for the risk and progression of lung
cancer. Vit-D is a steroid hormone that is now widely
accepted that it exerts several extraskeletal actions, includ-
ing anti-tumorigenic and immunomodulatory effects in
vitro and in vivo. Its potential in cancer prevention and
treatment is currently under detailed investigation.With
the prospect of more effective therapeutic options for
advanced stage disease, there are still insufficient current
follow-up procedures for lung cancer. Therefore, in the
present study, we investigated the concentrations of
sCD200,sTRAIL,Vit-D,Hcy in the peripheral blood of
metastatic non-smalcelllungcancer(MNSCLC) patients. As
well as the corresponding F-18-Deoxyglucosepositrone-
missiontomography (PET/CT) results were evaluate
Methods
Consecutive 22 adenocarcinoma and15 squamous cell car-
cinoma patients of MNSCLC referred to our institute
were included in this study.The sCD200, sTRAIL, Hcy and
Vit-D concentrations in the serum samples from the37
NSCLC patients were analyzed using a TRAIL/APO2L
ELISA kit (Diaclone, France) and Roche kit for Vit-D and
Hcy according to the manufacturer’s instructions. The
absorbance of each patient on a spectrophotometer using
450 nm and the concentration of sTRAIL(pg/mL),
sCD200(pg/mL), Hcy(mmol/L) and Vit-D(ng/mL) was
measured.
Results
levels of sCD200, sTRAIL, Vit-D, Hcy are not to be core-
lated with survival in patients with MNSCLC.In patients
with squamous cell carcinoma SUVMAX and survival
are found to be corelated. The correlation is r=-0.6954,
p=0.004, n=15.The data were evaluated using the Sta-
taMP software package, version 12.1 (StataCorp, College
Station, TX,USA) on a Mac Pro 2x2.93 GHz, 2*6 Core
Intel Xeon system with 24GB RAM using Mac
OSX10.7.4 (Apple, Cupertino,CA,USA). An error level of
p<0.05 was generally used for the statistical analysis. The
Wilcoxon matched pairs signed rank test was used to
assess differences in the variables prior and three months
after onset of treatment. Correlation tables were calcu-
lated for all variables. Furthermore, a multivariate corre-
lation/regression analysis was applied to the data, using
the survival as the dependent variable.
Conclusion
F-18-Deoxyglucose(FDG), a glucose analogue, is an
advanced imaging technique and allows a highly sensitive
whole body search for malignant foci, which are detected
by their increased glucose metabolism versus benign tis-
sues, and successful scanning has been performed in a
wide variety of cancers.
Author details
1Internal Medicine, Allergy and Immunology, Education and Research
Hospital, Turkey. 2Department of Nuclear Medicine, Akdeniz University
Hospital, Turkey. 3Medical Park Hospital, Turkey. 4Department of Internal
Medicine, Antalya Education and Research Hospital, Antalya, Turkey.
5Department of Internal Medicine, Oncology Unit, Akdeniz University
Hospital, Antalya, Turkey. 6Clinical Cooperation Unit Nuclear Medicine,
German Cancer Research Center, Im Neuenheimer Feld 280, 69120,
Heidelberg, Germany.
1Internal Medicine, Allergy and Immunology, Education and Research
Hospital, Turkey
Full list of author information is available at the end of the article
Yalcin et al. World Allergy Organization Journal 2013, 6(Suppl 1):P207
http://www.waojournal.org/content/6/S1/P207
© 2013 Yalcin et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Published: 23 April 2013
doi:10.1186/1939-4551-6-S1-P207
Cite this article as: Yalcin et al.: Basic and clinical immunology – 3032.
18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-
4 squamous cell carcinoma. World Allergy Organization Journal 2013
6(Suppl 1):P207.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yalcin et al. World Allergy Organization Journal 2013, 6(Suppl 1):P207
http://www.waojournal.org/content/6/S1/P207
Page 2 of 2
